Lynn Sullivan
Chief Business Officer Rose Pharma
Lynn is a pioneer in commercializing GLP-1 therapies, having led the launches of Ozempic®, Saxenda®, Wegovy®and oral Ozempic® called Rybelsus®. With 30+ years of experience bringing novel drug mechanisms and new therapeutic categories to market - including Prilosec®, Actos®, and Humira® - She has a proven track record of shaping strategy and building blockbuster brands in emerging markets. Today, she leads a biotech company with a Phase 2 product being advanced with two indications: Reduction of IBS Pain and Weight Management.
Check out the incredible speaker line-up to see who will be joining Lynn.
Download The Latest AgendaIn Partnership With:
QUESTIONS?
Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk
©2026 IQPC. All rights reserved.
